Budget Reaction from Meril Life Sciences for your reference

Budget Reaction from Meril Life Sciences for your reference

Mr Sanjeev Bhatt, Senior Vice President of Corporate Strategy at Meril Life Sciences

“The Union Budget 2025-26 reflects a bold and visionary commitment to strengthening India’s healthcare ecosystem. The substantial investment in infrastructure, medical education, and AI-driven diagnostics will not only enhance accessibility but also position India as a global leader in healthcare innovation. The exemption of Basic Customs Duty on lifesaving drugs is a transformative step towards affordability for patients battling critical illnesses. As we work towards bridging the urban-rural healthcare divide, these strategic initiatives will pave the way for a healthier, more resilient nation. We welcome this progressive budget and look forward to collaborating with the government to drive meaningful advancements in the sector”.